Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
38 studies found for:    Amenorrhea: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Amenorrhea: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Condition: Amenorrhea
Interventions: Drug: DR-2021a;   Drug: DR-2021b;   Drug: DR-2021c;   Drug: DR-2021d;   Drug: DR-2021e;   Other: Placebo
2 Terminated A Phase 3, Randomized, Three-Cycle, Double-Blind, Placebo-Controlled Study to Evaluate Induction of Secretory Conversion of Endometrium and Withdrawal Bleeding for Secondary Amenorrhea
Condition: Secondary Amenorrhea
Intervention: Drug: Progesterone
3 Terminated
Has Results
The Luveris In Vitro Fertilization Trial
Conditions: Infertility;   Hypothalamic Amenorrhea;   Hyperprolactinemia
Interventions: Drug: Luveris fixed dose;   Drug: Luveris increasing dose
4 Active, not recruiting Study of Leptin for the Treatment of Hypothalamic Amenorrhea
Condition: Amenorrhea
Interventions: Drug: r-metHuLeptin;   Drug: Oral Contraceptive Pills (OCPs)
5 Active, not recruiting Analgesic Effect of Maternal Breast Milk Odor in Preterm Neonates: a Randomised Controlled Trial
Condition: Neonates Analgesy
Interventions: Other: maternal breast milk odor;   Other: no odor
6 Unknown  CavatermTM vs TCRE in Women With DUB
Condition: Dysfunctional Uterine Bleeding
Interventions: Device: Thermal Balloon Endometrial Ablation;   Device: Transcervical Resection of the Endometrium
7 Recruiting Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients
Condition: Breast Cancer Nos Premenopausal
Interventions: Drug: Docetaxel;   Drug: epirubicin;   Drug: cyclophosphamide;   Procedure: Modified radical mastectomy or breast-conserving Surgery;   Drug: Docetaxel (post-operative);   Drug: Epirubicin (post-operative);   Drug: Cyclophosphamide (post-operative);   Radiation: Radiation therapy;   Drug: Herceptin (post-operative);   Drug: Tamoxifen (post-operative)
8 Recruiting Anti-Mullerian Hormone Study. ICORG 10-16, V2
Conditions: Premenopausal Breast Cancer;   Breast Cancer
Intervention:
9 Unknown  Trial of AMNIOECHANGE in Gastroschisis Affected Foetuses
Condition: Gastroschisis
Intervention: Procedure: AMNIOECHANGE
10 Completed Effect of Hormone Replacement Therapy on Lupus Activity
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
11 Completed Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
Condition: Intrauterine Adhesion
Interventions: Device: Crosslinked hyaluronic acid gel;   Device: Foleys balloon catheter
12 Recruiting A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
Condition: Contraception
Interventions: Drug: Levonorgestrel (13,5 mg) intrauterine device;   Device: Cooper (380mm2) intrauterine device
13 Completed Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Conditions: Breast Cancer;   Infertility;   Menopausal Symptoms
Interventions: Drug: cyclophosphamide;   Drug: goserelin acetate;   Procedure: adjuvant therapy;   Procedure: fertility assessment and management;   Procedure: neoadjuvant therapy
14 Completed Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis
Condition: the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis
Intervention: Drug: received oral letrozole (2.5 mg/day)and goserelin subcutaneosly (3.6 mg/month)
15 Completed A Study to Compare the Effectiveness of Two Different Outpatient Endometrial Ablation Techniques Used for Heavy Periods
Condition: Menorrhagia
Interventions: Device: NovaSure;   Device: thermachoice
16 Recruiting Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Conditions: Polycystic Ovary Syndrome;   Non-Alcoholic Fatty Liver Disease;   Metabolic Syndrome
Interventions: Drug: Metformin;   Drug: Placebo
17 Active, not recruiting Efficacy of the Female Athlete Body Project (FAB)
Conditions: Eating Disorders;   Female Athlete Triad
Interventions: Behavioral: Healthy Weight;   Other: Brochure
18 Completed
Has Results
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: docetaxel;   Drug: doxorubicin
19 Unknown  Hormone Replacement Therapy and Insulin Action: A Double-Blind, Parallel, Placebo-Controlled Hormone Intervention Study in Postmenopausal Women
Condition: Menopause
Intervention: Drug: Hormone Replacement Therapy
20 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.